• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Biomed Pharmacother . Epidemiology, clinical ramifications, and cellular pathogenesis of COVID-19 mRNA-vaccination-induced adverse cardiovascular o

tetano

Editor, Senior Moderator
Biomed Pharmacother


. 2022 Mar 21;149:112843.
doi: 10.1016/j.biopha.2022.112843. Online ahead of print.
Epidemiology, clinical ramifications, and cellular pathogenesis of COVID-19 mRNA-vaccination-induced adverse cardiovascular outcomes: A state-of-the-heart review


Talal Almas[SUP] 1 [/SUP], Sarah Rehman[SUP] 2 [/SUP], Eyad Mansour[SUP] 3 [/SUP], Tarek Khedro[SUP] 3 [/SUP], Ali Alansari[SUP] 4 [/SUP], Jahanzeb Malik[SUP] 5 [/SUP], Norah Alshareef[SUP] 3 [/SUP], Vikneswaran Raj Nagarajan[SUP] 3 [/SUP], Abdulla Hussain Al-Awaid[SUP] 3 [/SUP], Reema Alsufyani[SUP] 3 [/SUP], Majid Alsufyani[SUP] 3 [/SUP], Ali Rifai[SUP] 3 [/SUP], Ahlam Alzahrani[SUP] 3 [/SUP], Dhineswaran Raj Nagarajan[SUP] 6 [/SUP], Tala Abdullatif[SUP] 7 [/SUP], Varman Gunasaegaram[SUP] 8 [/SUP], Enaam Alzadjali[SUP] 3 [/SUP], Arthi Subramanian[SUP] 3 [/SUP], Abida Rahman[SUP] 9 [/SUP], Yasar Sattar[SUP] 10 [/SUP], Jason Galo[SUP] 11 [/SUP], Hafeez Ul Hassan Virk[SUP] 12 [/SUP], M Chadi Alraies[SUP] 13 [/SUP]



Affiliations

Abstract

The coronavirus disease 2019 (COVID-19) has overwhelming healthcare systems globally. To date, a myriad of therapeutic regimens has been employed in an attempt to curb the ramifications of a severe COVID-19 infection. Amidst the ongoing pandemic, the advent and efficacious uptake of COVID-19 vaccination has significantly reduced disease-related hospitalizations and mortality. Nevertheless, many side-effects are being reported after COVID-19 vaccinations and myocarditis is the most commonly reported sequelae post vaccination. Majority of these diseases are associated with COVID-19 mRNA vaccines. Various studies have established a temporal relationship between these complications, yet the causality and the underlying pathogenesis remain hypothetical. In this review, we aim to critically appraise the available literature regarding the cardiovascular side effects of the various mRNA vaccines and the associated pathophysiology.

Keywords: COVID-19 mRNA vaccine; COVID-19 myocarditis; COVID-19 perimyocarditis; Coronavirus 2019 (COVID-19); SARS-CoV-2; Takotsubo syndrome.
 
Back
Top Bottom